Inhibition of corneal neovascularization by recombinant adenovirus-mediated sFlk-1 expression
- 1 August 2007
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 361 (4), 946-952
- https://doi.org/10.1016/j.bbrc.2007.07.114
Abstract
The interaction of vascular endothelial growth factor (VEGF) and its receptors (Flt-1, Flk-1/KDR) is correlated with neovascularization in the eyes. Therefore, blocking the binding of VEGF and the corresponding receptor has become critical for inhibiting corneal neovascularization. In this study, we have expressed the cDNA for sFlk-1 under the control of cytomegalovirus immediate-early promoter (CMV) from an E1/partial E3 deleted replication defective recombinant adenovirus, and Ad.sflk-1 expression was determined by Western blotting. We have shown that conditioned media from Ad.sflk-1-infected ARPE-19 cells significantly reduced VEGF-induced human umbilical vein endothelial cells (HUVEC) and murine endothelial cells (SVEC) proliferation in vitro compared with the control vector. In vivo, adenoviral vectors expressing green fluorescent protein alone (Ad.GFP) were utilized to monitor gene transfer to the cornea. Moreover, in the models of corneal neovascularization, the injection of Ad.sflk-1 (108 PFU) into the anterior chamber could significantly inhibit angiogenic changes compared with Ad.null-injected and vehicle-injected models. Immunohistochemical analysis showed that corneal endothelial cells and corneal stroma of cauterized rat eyes were efficiently transduced and expressed sFlk-1. These results not only support that adenoviral vectors are capable of high-level transgene expression but also demonstrate that Ad.sflk-1 gene therapy might be a feasible approach for inhibiting the development of corneal neovascularization.Keywords
This publication has 19 references indexed in Scilit:
- Inhibition of Corneal Neovascularization by Recombinant Adenovirus Mediated Antisense VEGF RNAExperimental Eye Research, 2002
- Corneal neovascularizationCurrent Opinion in Opthalmology, 2001
- CD18 and ICAM-1-Dependent Corneal Neovascularization and Inflammation after Limbal InjuryThe American Journal of Pathology, 2000
- Ocular NeovascularizationSurvey of Ophthalmology, 1998
- Mechanisms of angiogenesisNature, 1997
- Endothelial receptor tyrosine kinases involved in angiogenesis.The Journal of cell biology, 1995
- Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium.Proceedings of the National Academy of Sciences of the United States of America, 1993
- High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesisCell, 1993
- Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factorBiochemical and Biophysical Research Communications, 1992
- The fms -Like Tyrosine Kinase, a Receptor for Vascular Endothelial Growth FactorScience, 1992